UA84205C2 - Method for evaluation of effectiveness of anti-oxidant effect at treatment of patients with acute cardiac infarction with corvitine - Google Patents

Method for evaluation of effectiveness of anti-oxidant effect at treatment of patients with acute cardiac infarction with corvitine

Info

Publication number
UA84205C2
UA84205C2 UAA200612088A UAA200612088A UA84205C2 UA 84205 C2 UA84205 C2 UA 84205C2 UA A200612088 A UAA200612088 A UA A200612088A UA A200612088 A UAA200612088 A UA A200612088A UA 84205 C2 UA84205 C2 UA 84205C2
Authority
UA
Ukraine
Prior art keywords
treatment
corvitine
patients
evaluation
oxidant effect
Prior art date
Application number
UAA200612088A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Марина Вячеславовна Филоненко
Николай Максимович Кишко
Александр Анатольевич Сабинин
Original Assignee
Ужгородский Национальный Университет
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ужгородский Национальный Университет filed Critical Ужгородский Национальный Университет
Priority to UAA200612088A priority Critical patent/UA84205C2/en
Publication of UA84205C2 publication Critical patent/UA84205C2/en

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention relates to medicine, in particular to method for evaluation of anti-oxidant effect of corvitin at its prescription to patients with acute miocarditial infarction. The method is in determination of activity in blood of ferment of superoxiddismutase by adenochromic method before and after treatment. If activity of ferment superoxyddismutase is increased by 20 % and more compared to level before treatment anti-oxidant effect of corvitine is positive.
UAA200612088A 2006-11-17 2006-11-17 Method for evaluation of effectiveness of anti-oxidant effect at treatment of patients with acute cardiac infarction with corvitine UA84205C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAA200612088A UA84205C2 (en) 2006-11-17 2006-11-17 Method for evaluation of effectiveness of anti-oxidant effect at treatment of patients with acute cardiac infarction with corvitine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAA200612088A UA84205C2 (en) 2006-11-17 2006-11-17 Method for evaluation of effectiveness of anti-oxidant effect at treatment of patients with acute cardiac infarction with corvitine

Publications (1)

Publication Number Publication Date
UA84205C2 true UA84205C2 (en) 2008-09-25

Family

ID=50724603

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200612088A UA84205C2 (en) 2006-11-17 2006-11-17 Method for evaluation of effectiveness of anti-oxidant effect at treatment of patients with acute cardiac infarction with corvitine

Country Status (1)

Country Link
UA (1) UA84205C2 (en)

Similar Documents

Publication Publication Date Title
AR109605A2 (en) METHOD FOR TREATING PERIPHERAL VASCULAR DISEASES, COMPOSITION AND USE
EP3447491A3 (en) Diagnosis and treatments relating to th2 inhibition
DE602006007093D1 (en) Combination therapy for the treatment of diabetes and related conditions as well as for the treatment of conditions that have been improved in the blood by increasing GLP-1 levels
EA202091999A3 (en) APPLICATION OF DPP IV INHIBITORS
MA32872B1 (en) Treatment of diabetes in patients with blood sugar is insufficient despite treatment with oral or other anti-diabetic drugs
EA200971053A1 (en) METHODS OF TREATMENT OF THE LEAD ULCERS
MX2019005130A (en) Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin.
MX2010004450A (en) Bicyclic heterocycle derivatives and methods of use thereof.
MX2010004074A (en) Combination 059.
WO2005113016A3 (en) Modulation of glucose-6-phosphatase translocase expression
MX2011007397A (en) Dpp-iv inhibitors for treatment of diabetes in paediatric patients.
WO2009086072A3 (en) Therapy of rituximab-refractory rheumatoid arthritis patients
MX2009003658A (en) Bicyclic nitrogen-containing heterocyclic compounds for use as stearoyl coa desaturase inhibitors.
WO2010091049A3 (en) Diagnosis and treatment of cancer
MX2009007247A (en) Method for the treatment of conditions associated with increased 5-lipoxygenase and/or leukotriene activity.
MX366496B (en) Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use.
EA201070918A1 (en) APPLICATION OF RANOLAZINE FOR THE TREATMENT OF CARDIOVASCULAR DISEASES
TW200738255A (en) Methods of regulating renalase (Monoamine Oxidase C)
HK1132461A1 (en) Agent comprising g-csf for prevention and treatment of diabetic peripheral neuropathy
UA84205C2 (en) Method for evaluation of effectiveness of anti-oxidant effect at treatment of patients with acute cardiac infarction with corvitine
BRPI0512342A (en) methods for bone augmentation
WO2008091408A3 (en) Circulating renalase and methods of increasing same
ATE498391T1 (en) LIQUID COMPOSITION FOR THE TREATMENT AND/OR PREVENTION OF VARIOUS METABOLIC BONE DISEASES, USE THEREOF AND PREPARATION PROCESS.
UA107787C2 (en) Method of assessment of the effectiveness of treatment s-metoprolol patients with coronary heart disease with angina and hypertension in violation of left ventricular diastolic function in "hypertrophic" type
UA40165U (en) Method for evaluation of level of cortizol in patients with ischemic cardiac disease